MedPath

A study on the role of far infra red therapy on arteriovenous fistula maturation and survival in hemodialysis patients.

Phase 3
Conditions
Health Condition 1: N186- End stage renal disease
Registration Number
CTRI/2024/06/069406
Lead Sponsor
Dan Elizabeth Sunny
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

CKD Stage 5

Planned for Primary AVF Creation

Exclusion Criteria

Complex vascular access procedure.

Repeat AVF Creation.

AVF site infection.

Not able to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the role of FIR therapy on AVF maturation <br/ ><br>2.Role of FIR therapy on AVF survivalTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
Correlation between imaging parameters & AVF survivalTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath